1015 - A multicenter evaluation of antimicrobial utilization in hospitalized bone marrow transplant (BMT) and T-cell therapy (CAR-T) patients, and the impact on rates of C. difficile infection (CDI)

Presenting Author(s)

• 

  Jerod Nagel, PharmD

  Infectious Diseases & Antimicrobial Stewardship Team Lead
  Michigan Medicine
  Ann Arbor, MI, United States

  Slides

Co-Author(s)

• KB

  Kimberly D. Boeser, PharmD, MPH, BCIDP

  ID Clinical Pharmacist, System Antimicrobial Stewardship Coordinator
  M Health Fairview, University of Minnesota Medical Center
  Minneapolis, Minnesota, United States
• CH

  Cory Hale, PharmD, BCPS, BCIDP

  Clinical Pharmacy Coordinator, Infectious Diseases
  Penn State Health Milton S. Hershey Medical Center
  Hershey, Pennsylvania, United States
• AH

  Alyssa Harris, MPH

  Vizient, Inc
  Chicago, Illinois, United States
• 

  Rupali Jain, PharmD

  Clinical Associate Professor
  University of Washington Medical Center-Montlake
  Seattle, WA, United States
• MP

  Mike Postelnick, BS Pharm, BCPS AQ Infectious Diseases

  Antimicrobial Stewardship Program Director
  Northwestern Medicine
  Chicago, Illinois, United States
• 

  Emily S. Spivak, MD, MHS (she/her/hers)

  Associate Professor of Medicine
  University of Utah School of Medicine
  Salt Lake City, UT, United States